Abiopharma

🔍 Cui Haitao (Director)

Company: Foxx Development Holdings Inc. (FOXX)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Sold 101 shares of Common Stock at $4.0 per share (Direct)
  Date: 2026-03-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 141,362.00 | transaction_form_type: 4
• Sold 3,888 shares of Common Stock at $4.04 per share (Direct)
  Date: 2026-03-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 137,474.00 | transaction_form_type: 4
• Sold 117 shares of Common Stock at $4.0 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 137,357.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents 40,101 vested and 97,256 unvested restricted shares from an initial grant of 141,463 restricted shares made on November 5, 2024. The remaining unvested restricted shares will continue to vest at a rate of 1/16th of the original grant amount on the quarterly anniversary date of the grant provided the reporting person remains in continuous service on each vesting date.